Iterative Health
Daniel Colucci is currently the Chief of Staff, Scientific and Regulatory Affairs at Iterative Health, the MIT-spun healthtech start-up bringing precision medicine to gastroenterology through AI. Prior to this role, they worked in Clinical Operations at Kaleido Biosciences, where they were involved in developing novel therapeutics targeting the microbiome. Additionally, they have experience as a Research Assistant at Beth Israel Deaconess Medical Center and Nema Research Inc, conducting research on movement disorders and pharmaceutical research, drug development, and pain management respectively. They also served as a Research Assistant in the Oakes Lab at Northeastern University, working on biofluids and transport research.
This person is not in any teams
This person is not in any offices
Iterative Health
1 followers
Iterative Health is pioneering the use of artificial intelligence-based precision medicine in gastroenterology (GI), with the aim of helping to optimize clinical trials investigating treatment of inflammatory bowel disease (IBD). We use advanced machine learning and computer vision to interpret endoscopic images along with other types of data, helping clinicians to better assess patients with potential GI problems. This gives practitioners enhanced capabilities in the detection, annotation, disease scoring and treatment of GI related diseases. Iterative Health is initially applying these advances towards standardizing disease severity characterization for inflammatory bowel disease. Ultimately, the company aims to establish more meaningful endpoints to serve as better predictors of both therapeutic response and disease outcomes. The company is headquartered in Cambridge, Massachusetts.
Employees
51-200